CTVA — Corteva, Inc.

Corteva Agriscience Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Performance: Organic sales decreased by 4% year-over-year, with Crop Protection volumes down 2% and prices down 1%. Seed pricing increased by 3% but volumes fell by 8% due to timing shifts.
• Full Year Results: Organic sales grew by 4%, with operating EBITDA up 14% to $3.85 billion, achieving an operating EBITDA margin of over 22%, a 215 basis point increase.
• Free Cash Flow: Improved significantly to $2.9 billion, up $1.2 billion from the previous year, driven by higher EBITDA and working capital discipline.

2. Strategic Updates and Business Highlights

• Separation Update: Corteva is on track for a separation in the second half of 2026, with a new CEO expected to be announced soon. The company is also preparing for an Investor Day in September.
• Bayer Agreement: A comprehensive resolution with Bayer allows Corteva to accelerate its licensing business, achieving royalty neutrality in 2026, two years ahead of schedule. This agreement enhances Corteva's market position in corn, cotton, and canola.
• Seed Business Growth: The Seed business saw organic growth across all regions, with significant cost improvements and share gains in North American corn and Brazilian soybeans.
• Crop Protection Pipeline: The Crop Protection business is benefiting from a $9 billion pipeline of differentiated technologies, with productivity and cost benefits of over $300 million for the year.

3. Forward Guidance and Outlook

• 2026 Guidance: Corteva expects operating EBITDA to be between $4.0 billion and $4.2 billion, representing a 7% growth at the midpoint. Operating EPS is projected to be between $3.45 and $3.70 per share.
• Market Dynamics: Anticipated modest growth in the Crop Protection market, with pricing pressures expected to persist, particularly in Latin America.
• Volume Expectations: Seed volumes are expected to be flat due to shifts in corn and soybean acreage, while Crop Protection volumes are projected to increase mid-single digits driven by new products.

4. Bad News, Challenges, or Points of Concern

• Q4 Declines: The fourth quarter saw declines in both Seed and Crop Protection volumes, coupled with increased SG&A and R&D expenses, which rose significantly compared to the previous year.
• Competitive Pricing Pressures: Ongoing competitive pricing dynamics in Latin America and Asia Pacific are impacting Crop Protection margins.
• Farmer Financial Stress: Farmers in Latin America are facing high interest rates and tight cash flows, which could affect purchasing decisions in 2026.

5. Notable Q&A Insights

• Bayer Agreement Clarifications: The agreement with Bayer allows Corteva to enter the cotton market and accelerates the introduction of proprietary corn technologies. However, future royalties on certain products will still apply.
• Gene Editing Developments: Corteva is optimistic about regulatory changes in Europe regarding gene editing, which could enhance market opportunities for their products.
• Order Book Strength: The U.S. order book for Seed is strong, with prepay levels comparable to the previous year, indicating confidence in upcoming sales despite potential shifts in crop acreage.

Overall, Corteva's Q4 2025 results reflect a solid year with strategic advancements, although challenges remain in terms of pricing pressures and farmer financial health. The outlook for 2026 appears cautiously optimistic, with growth anticipated in both Seed and Crop Protection segments.